Global Non-invasive Preimplantation Genetic Testing Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Non-invasive Preimplantation Genetic Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).

This report is a detailed and comprehensive analysis for global Non-invasive Preimplantation Genetic Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Non-invasive Preimplantation Genetic Testing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Non-invasive Preimplantation Genetic Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Non-invasive Preimplantation Genetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Non-invasive Preimplantation Genetic Testing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Non-invasive Preimplantation Genetic Testing

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Non-invasive Preimplantation Genetic Testing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Non-invasive Preimplantation Genetic Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Market segment by Application
Hospitals
Diagnostic Laboratories
Other

Major players covered
Illumina
Thermo Fisher Scientific
Agilent
Revvity
The Cooper Companies
Abbott
TAKARA
QIAGEN
Vitrolife
Oxford Nanopore Technologies
Yikon Genomics
Shiva Scientific
Medicover Genetics
MedGenome
Fulgent
INVICTA GENETICS
Genea Fertility
Bioarray
GeneMind Biosciences
Unimed Biotech

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Non-invasive Preimplantation Genetic Testing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Non-invasive Preimplantation Genetic Testing, with price, sales quantity, revenue, and global market share of Non-invasive Preimplantation Genetic Testing from 2020 to 2025.

Chapter 3, the Non-invasive Preimplantation Genetic Testing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Non-invasive Preimplantation Genetic Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Non-invasive Preimplantation Genetic Testing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Non-invasive Preimplantation Genetic Testing.

Chapter 14 and 15, to describe Non-invasive Preimplantation Genetic Testing sales channel, distributors, customers, research findings and conclusion.